Patents Assigned to New Form Pharmaceuticals, Inc.
  • Cocrystallization
    Patent number: 8350085
    Abstract: The present disclosure relates to novel cocrystals and novel methods for cocrystallization. In particular, the disclosure includes cocrystals comprising a salt of an active agent, such as a chloride salt of an active pharmaceutical ingredient. The present disclosure also relates to methods of preparing cocrystals and methods for screening for solid state phases.
    Type: Grant
    Filed: June 28, 2011
    Date of Patent: January 8, 2013
    Assignee: New Form Pharmaceuticals Inc.
    Inventor: Scott L. Childs
  • Metronidazole cocrystals and imipramine cocrystals
    Patent number: 8163790
    Abstract: Cocrystals of metronidazole are described herein. Such cocrystals are a cocrystal of metronidazole with gentisic acid and a cocrystal of metronidazole with gallic acid. Cocrystals of imipramine hydrochloride are also described. Such cocrystals are a cocrystal of imipramine hydrochloride with (+)-camphoric acid, a cocrystal of imipramine hydrochloride with fumaric acid, and a cocrystal of imipramine hydrochloride with 1-hydroxy-2-naphthoic acid.
    Type: Grant
    Filed: December 8, 2006
    Date of Patent: April 24, 2012
    Assignee: New Form Pharmaceuticals, Inc.
    Inventor: Scott Lawrence Childs